Skye Bioscience SKYE Growth Metrics (2013-2026)

NASDAQ SKYE
$2.23 +0.35 (+18.62%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Skye Bioscience Quarterly Growth Metrics

Periods 50 quarters
Latest Jun 2026

Skye Bioscience growth metrics data for the quarter ended Jun 2026. These growth metrics cover 50 quarters of results from Apr 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Apr2013 Jul2013 Oct2013 Apr2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
EBITDA Margin (QoQ)
EBIT Margin Growth (1y)
EBIT Margin (QoQ)
EBT Margin Growth (1y)
EBT Margin (QoQ)
FCF Margin Growth (1y)
FCF Margin (QoQ)
Gross Margin Growth (1y)
Gross Margin (QoQ)
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-10.55%-74.40%-54.44%-62.84%-48.57%-1,412.66%-1,061.41%2.72%-558.22%94.93%91.64%-22.47%160.12%2,493.22%-57,418.61%28.83%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
18.72%-3.59%-37.55%-40.53%-208.54%-133.18%-28.95%-121.11%-10.20%-14.44%-24.72%98.99%173.08%-723.35%-224.60%-503.56%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
-38.40%16.25%-1.53%-25.40%66.98%106.62%-260.55%-261.04%-222.39%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
3.27%-32.96%-17.20%-8.04%11.75%-1,253.64%10.01%90.95%-497.14%89.57%-48.22%-32.64%393.11%315.31%-3,662.22%41.83%
Net Margin Growth (1y)
Net Margin (QoQ)
Operating Margin Growth (1y)
Operating Margin (QoQ)
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.01M0.01M0.00M-0.00M-0.02M-0.02M-0.02M-0.04M-0.02M0.01M0.02M0.06M0.05M0.02M0.00M-0.00M-0.01M-0.01M-0.02M-0.03M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.08M0.12M0.03M-0.03M-0.04M-0.11M-0.13M0.02M-0.05M-0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.02M0.02M0.01M0.03M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.02M0.05M0.05M0.06M0.06M0.04M0.02M-0.02M0.04M0.10M0.03M-0.02M-0.02M-0.08M-0.11M0.08M-0.01M0.00M-0.01M-0.02M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M835.00-0.00M-0.01M-0.01M-0.00M978.00-0.03M0.01M0.02M0.02M0.00M0.00M-927.00-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.05M0.01M0.00M-0.11M0.06M0.04M0.09M0.15M0.03M2.67M-0.08M-0.03M-0.09M-2.70M0.00M-0.00M-0.01M-0.02M-0.04M-0.13M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.01M-0.01M-0.02M-0.13M0.05M0.10M-0.15M-0.01M0.15M2.72M0.01M0.01M0.01M0.01M0.02M0.11M-0.07M-0.05M-0.12M-0.17M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
1.03M-0.30M-0.19M-0.18M0.02M-0.08M0.10M0.02M0.08M2.70M-0.01M-0.01M-0.01M0.07M-0.23M-0.05M0.05M0.00M-0.02M-0.12M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.01M-0.00M-0.01M-0.10M0.17M-0.02M0.04M-0.05M0.05M2.62M-2.71M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.02M-0.10M
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
-0.30M0.03M400.00-0.03M-0.05M2.84M-0.08M0.02M0.05M-2.82M0.12M0.04M0.00M-0.00M-0.01M-0.02M-0.03M-0.05M
Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y)
0.02M0.03M-0.24M-0.08M-0.14M2.78M-0.41M-613.000.01M0.01M0.01M0.01M0.03M0.04M0.02M-2.88M
Return on Invested Capital [ROIC] Growth (5y)ROIC Growth (5y)
2.84M-0.10M-0.00M-0.23M-0.04M-0.08M-0.04M-0.30M0.02M-0.04M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
0.01M0.00M-0.03M-0.01M0.00M2.88M-2.94M0.08M0.03M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.03M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
Return on Sales [ROS] (QoQ)ROS (QoQ)